SECTOR GAMMA AS - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
SECTOR GAMMA AS ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$4,105,668
-11.5%
115,166
+14.5%
1.05%
+1.1%
Q2 2023$4,640,909
+8.9%
100,605
-5.3%
1.04%
+0.5%
Q1 2023$4,261,908
+102.1%
106,282
+133.5%
1.03%
+114.3%
Q4 2022$2,108,942
+11.9%
45,5200.0%0.48%
-0.8%
Q3 2022$1,885,000
-31.7%
45,520
-1.5%
0.49%
-21.2%
Q2 2022$2,758,000
-17.8%
46,2210.0%0.62%
-15.4%
Q1 2022$3,357,000
-60.5%
46,221
-57.5%
0.73%
-58.5%
Q2 2020$8,505,000
+31.9%
108,734
-25.0%
1.76%
+27.8%
Q1 2020$6,446,000
-29.9%
145,072
-32.6%
1.37%
-6.7%
Q4 2019$9,191,000
+24.2%
215,196
+24.4%
1.47%
+17.8%
Q3 2019$7,400,000
+46.3%
172,978
+117.2%
1.25%
+53.8%
Q2 2019$5,058,000
+10.6%
79,653
+20.8%
0.81%
+10.9%
Q1 2019$4,573,000
+1214.1%
65,935
+724.2%
0.73%
+1142.4%
Q4 2018$348,000
-84.5%
8,000
-72.8%
0.06%
-83.2%
Q3 2018$2,242,000
-57.1%
29,368
-56.8%
0.35%
-59.5%
Q2 2018$5,228,00068,0150.87%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders